Literature DB >> 502352

[Duration of biological activity of pindolol in uremics (author's transl)].

H M Herb, V Heinze.   

Abstract

The duration of biological activity of pindolol following short and long term application was tested using a modified isoproterenol-sensitivity-test. Following a single dose of pindolol the beta-blocking activity in uremics was increased to twice the activity seen in normal controls. Following daily oral application of 10 mg Pindolol over a number of weeks the beta-blockade observed in patients with chronic renal failure was significantly stronger and the duration of action was 6 times longer than in normal controls.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 502352     DOI: 10.1007/bf01477991

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  5 in total

1.  Relationship between renal function and elimination kinetics of pindolol in man.

Authors:  S Oie; G Levy
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

2.  Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia.

Authors:  E E Ohnhaus; E Nüesch; J Meier; F Kalberer
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

4.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

5.  The response of heart rate to isoproterenol in hemodialyzed patients before and after parathyroidectomy.

Authors:  A Ulmann; T Drüeke; J Zingraff; J Crosnier
Journal:  Clin Nephrol       Date:  1977-02       Impact factor: 0.975

  5 in total
  1 in total

1.  Metabolism of pindolol in patients with renal failure.

Authors:  E E Ohnhaus; H Heidemann; J Meier; G Maurer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.